share_log

FDA Says Shortage of Eli Lilly's Zepbound Is Over, but Gives Compounders a Grace Period -- Barrons.com

FDA Says Shortage of Eli Lilly's Zepbound Is Over, but Gives Compounders a Grace Period -- Barrons.com

美國食品藥品管理局表示,禮來公司Zepbound的短缺已經結束,但爲複合商提供了寬限期 — Barrons.com
Barron's ·  12/20 02:03

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論